7 / 1023
Tumour targeting - considering normal tissue biology (Abs. 98-101)
Debate
This house believes that progress in the treatment of locally
advanced NSCLC will come from: (Abs. 102-103)
Symposium
Active surveillance for low risk prostate cancer: to treat or not to
treat? (Abs. 104-106)
Achieving excellence in image guided brachytherapy (Abs. 107-109)
Imaging markers for response prediction and assessment (Abs. 110-112)
Debate
There are many existing IGRT options for highly accurate dose
delivery. Is there a need for large-scale in-room MR-guidance? (Abs.
113-114)
Symposium
Additional tools for contouring (Abs. 115-117)
Poster Viewing
3: Clinical: Gastrointenstinal and gynaecology (Abs. 118-125)
Joint Symposium
ESTRO-ESR: MR-PET (Abs. 126-128)
Proffered Papers
Radiobiology 2: Interplay between cancer stem cells ,hypoxia and the
radiation response (Abs. 129-134)
Clinical 3: Lung (Abs. 135-140)
Clinical 4: Late breaking abstracts (Abs. 141-146)
Brachytherapy 2: EYE GI (Abs. 147-152)